⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BHC News
Bausch Health Companies Inc
Growth Factors Market to Reach US$ 3.7 Bn by 2033, Expands Amid Rising Regenerative Medicine and Biopharmaceutical Innovation - Persistence Market Research
prnewswire.com
TMO
MRK
BIO
BIIB
AMGN
GILD
REGN
CRSP
NTLA
BMY
ABBV
AZN
NVS
PFE
JNJ
MRNA
BNTX
COR
STEM
ALGN
EXAS
MDLZ
BHC
CVS
UNH
CI
CNC
ELAN
ZTS
ISRG
QRVO
SWKS
AVGO
QCOM
INTC
MSFT
GOOG
AMZN
IBM
ORCL
CRM
ADBE
NFLX
DIS
MCD
SBUX
KO
PEP
PG
JPM
BAC
WFC
C
GS
MS
AXP
V
MA
HD
LOW
COST
TGT
WMT
BBY
CMCSA
VZ
T
XOM
CVX
SIRI
UBER
LYFT
NVDA
AMD
MU
AMAT
LRCX
ASML
ADI
TXN
QGEN
ILMN
VRTX
EDIT
BEAM
SRPT
ACAD
ALKS
MDT
SYK
DHR
GOOGL
Conjunctivitis Market to Reach $61.6 Billion by 2033 Globally, at 13.8% CAGR: Allied Market Research
prnewswire.com
ABBV
JNJ
BHC
NVS
Intraocular Lens Market Poised for Strong Growth as Rising Cataract Procedures and Premium Vision Correction Demand Accelerate: Verified Market Research®
prnewswire.com
ALC
BHC
JNJ
SGA
ABT
Energy-Based Aesthetic Devices Market Research Report 2026-2031: Advancements in Laser and RF Systems, Rising Consumer Demand and Geographic Expansion Accelerate Revenue Opportunities
globenewswire.com
BHC
CTRA
Bausch Health Announces 2026 Gastrointestinal Health Scholars Program
prnewswire.com
BHC
United States Ophthalmic Viscoelastic Devices (Cohesive OVD, Dispersive OVD and Viscoadaptive OVD) Market Outlook to 2033
globenewswire.com
BHC
ALC
JNJ
Medical Aesthetics Market worth $40.70 billion by 2031 | MarketsandMarkets™
prnewswire.com
ABBV
JNJ
BHC
CTRA
Decentralized Clinical Trials Industry 2026-2032: Regional Challenges and Opportunities in Emerging Markets
globenewswire.com
BHC
ICLR
IQV
LH
Molecular Switch Targeting Therapies Market Research Report 2026: Opportunities in Targeted Drug Delivery Systems and Therapies in Oncology, Autoimmune, Inflammatory, and Neurological Disorders
globenewswire.com
MRK
BMY
AZN
PFE
NVS
LLY
GILD
JNJ
REGN
ABBV
NVO
SNY
VRTX
AMGN
BIIB
INCY
EXEL
SRPT
CRSP
EDIT
NTLA
ALNY
MRNA
BNTX
COHR
IMUX
INSM
CYTK
KODK
LULU
NVDA
GOOG
MSFT
IBM
AMAT
ILMN
ALKS
ACAD
MNKD
TEVA
BHC
XBI
IBB
XLF
XLK
XLV
JAZZ
ACGL
Bausch Health Provides Update on RED-C Phase 3 Clinical Trials
prnewswire.com
BHC